Corient Private Wealth LLC Increases Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Corient Private Wealth LLC increased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 16.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 8,182 shares of the biotechnology company’s stock after acquiring an additional 1,146 shares during the quarter. Corient Private Wealth LLC’s holdings in Axon Enterprise were worth $4,863,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Public Sector Pension Investment Board lifted its position in Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after buying an additional 500 shares in the last quarter. Soros Capital Management LLC purchased a new position in Axon Enterprise during the third quarter worth approximately $630,000. Friedenthal Financial lifted its position in Axon Enterprise by 961.7% during the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after buying an additional 1,231 shares in the last quarter. Principal Financial Group Inc. lifted its position in Axon Enterprise by 33.1% during the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after buying an additional 33,869 shares in the last quarter. Finally, XTX Topco Ltd increased its stake in Axon Enterprise by 20.6% during the third quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock worth $2,258,000 after acquiring an additional 964 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Robert W. Baird raised their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Barclays reissued a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Finally, JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Trading Up 0.3 %

AXON opened at $560.00 on Friday. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The stock has a market capitalization of $42.91 billion, a price-to-earnings ratio of 144.70, a PEG ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business has a fifty day moving average price of $591.90 and a 200 day moving average price of $540.96.

Insider Buying and Selling

In related news, insider Jeffrey C. Kunins sold 1,035 shares of the business’s stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the transaction, the insider now directly owns 124,243 shares of the company’s stock, valued at $77,586,026.21. The trade was a 0.83 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,792 shares of company stock valued at $1,087,843 in the last three months. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.